Clinical Trial Update: Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

View source ↗

Summary

Completed clinical trial evaluating the proportion of patients with immune thrombocytopenia who correctly self-administer romiplostim after home administration …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Immune Thrombocytopenic Purpura | Status: COMPLETED